Diagnostic Characterization and Evolution of "Triple Negative" Thrombocytosis (CASTETTE)

N/AActive Not RecruitingNCT06481332

University Hospital, Brest300 enrolled

Overview

Evaluation of Event free survival in patients with triple-negative thrombocytosis

Patients with non-reactive thrombocytosis, explored at least by bone marrow biopsy and NGS panel will be included. Clinical and biological characteristics as well as evolution will be recorded retrospectively.

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

Myeloproliferative Neoplasm

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with non reactive thrombocytosis for at least 6 months * availability of bone marrow biopsy and NGS panel Exclusion Criteria: * Unable to consent

Locations (1)

Chu Brest

Brest, France

Outcomes

Primary Outcomes

Event-free survival

Time frame: 3 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.